Results 31 to 40 of about 30,877 (270)

A growing evidence base for the fixed-dose combination of bisoprolol and amlodipine to manage hypertension

open access: yesCurrent Medical Research and Opinion, 2022
Objectives Hypertension is a major cause of morbidity and mortality worldwide. Although current drug therapies can be effective, management of hypertension is closely linked to patient adherence to therapy.
Ulrike Hostalek-Gottwald, Z. Gaciong
semanticscholar   +1 more source

Non-adherence to cardiovascular pharmacotherapy in Iraq assessed using 8-items Morisky questionnaire and analysis of dried blood spot samples [PDF]

open access: yes, 2019
open access journalThe study evaluated the non-adherence to selected cardiovascular medications, atenolol, atorvastatin, bisoprolol, diltiazem, lisinopril, simvastatin and valsartan in Iraqi patients by applying a standardized Morisky questionnaire (8 ...
Alalaqi, Ahmed   +3 more
core   +1 more source

Effectiveness of bisoprolol versus other β-blockers and other antihypertensive classes: a cohort study in the Clinical Practice Research Datalink.

open access: yesJournal of Comparative Effectiveness Research, 2022
Aim: To compare blood pressure (BP) and safety outcomes in patients with hypertension initiating bisoprolol, versus other β-blockers, angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers, calcium channel blockers or diuretics ...
C. Foch   +5 more
semanticscholar   +1 more source

Chronic beta-adrenoceptor blockade and human atrial cell electrophysiology: evidence of pharmacological remodelling [PDF]

open access: yes, 2003
<b>Objective:</b> Chronic beta-adrenoceptor antagonist (β-blocker) treatment reduces the incidence of reversion to AF in patients, possibly via an adaptive myocardial response.
Kane, K.A.   +4 more
core   +1 more source

Tolerability of Bisoprolol on Domiciliary Spirometry in COPD [PDF]

open access: yes, 2018
We investigated if serial domiciliary measures of spirometry were sensitive at detecting subtle effects of beta-2 blockade associated with bisoprolol in (n = 17) patients with COPD.
B Lipworth   +12 more
core   +2 more sources

To Evaluate the 'Real World' Clinical Performance of Bisoprolol in Post-Myocardial Infarction with Left Ventricular Dysfunction: Tenacity Study.

open access: yesJournal of Association of Physicians of India, 2022
Beta-blockers are the cornerstone in management of heart failure and are well studied in Acute Coronary Syndromes (ACS). There is paucity of data of Bisoprolol in acute ICU setting in patients admitted with left ventricular systolic dysfunction (LVSD ...
K. Sharma   +5 more
semanticscholar   +1 more source

Bisoprolol and Bisoprolol-Valsartan Compatibility Studied by Differential Scanning Calorimetry, Nuclear Magnetic Resonance and X-Ray Powder Diffractometry [PDF]

open access: yes, 2014
Purpose The objective of this study was to evaluate the thermal behavior of crystalline and amorphous bisoprolol fumarate and its compatibility with amorphous valsartan.
Juan A. Aguilar   +3 more
core   +3 more sources

Identification of Potential Drug Interaction with Complementary and Alternative Medicines Among Chronic Disease Outpatients [PDF]

open access: yes, 2018
Chronic diseases such as congestive heart failure (CHF) and chronic kidney disease (CKD) are related with multiple drug prescription which can lead to drug interaction.
Fajria, A. K. (Arsitania)   +2 more
core   +2 more sources

Lack of Effects of Renin-Angiotensin-Aldosterone System Activity and Beta-Adrenoceptor Pathway Polymorphisms on the Response to Bisoprolol in Hypertension

open access: yesFrontiers in Cardiovascular Medicine, 2022
Purpose This study examined the effects of plasma renin activity (PRA), angiotensin II (Ang II) and aldosterone (PAC) concentrations as well as common polymorphisms in the β1-Adrenoceptor gene (ADRB1) and the G-protein α-Subunit (Gαs) protein gene the G ...
Weiwei Zeng   +7 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy